$BIAFJun 17, 2026, 2:42 PMAI processed
bioAffinity prices $3.2M offering — 4.0M shares/pre-funded warrants at $0.80, close ~Jun 18
AI Summary
BioAffinity priced a public offering of 4,000,000 shares of common stock (or pre-funded warrants in lieu) at $0.80 per share (pre-funded warrants at $0.793), for aggregate gross proceeds of $3.2M. The pre-funded warrants are immediately exercisable; closing is expected on or about June 18, 2026, with WallachBeth Capital as sole placement agent. Timing: Same-day dilution is possible, but the press release does not provide a firm first-dilution date.
Positives
- Gross proceeds of approximately $3.2M expected
- Closing is scheduled on or about 2026-06-18, so issuance/dilution is delayed until closing
Negatives
- 4,000,000 shares/pre-funded warrants will increase share count materially at closing
- Pre-funded warrants are immediately exercisable, enabling near-term conversion to common shares
- Raise size is modest relative to share count, implying meaningful dilution per dollar raised
Filing Context
Filing and Dilution Context
Earliest dilution
Earliest dilution: date unknown
Dilution status
conditional
Dilution timing
Dilution status: Undetermined
Trigger type
exercise